Inventor · disambiguated record
Mamoun M. Alhamadsheh
Also filed as: ALHAMADSHEH MAMOUN · ALHAMADSHEH MAMOUN M
20 granted patents·8 pending applications·130 citations·filing 2006–2025
95Inventor score
Files withUNIV LELAND STANFORD JUNIOR14ALHAMADSHEH MAMOUN M6EIDOS THERAPEUTICS INC5GRAEF ISABELLA A1TILLEKERATNE VIRANGA1
Top patents by PatentIndex Score
28 records- 0196US10039726B2Identification of stabilizers of multimeric proteinsUNIV LELAND STANFORD JUNIOR·Filed 2016·Granted Aug 7, 2018·10 cites·19 claims
- 0295US10278929B2Identification of stabilizers of multimeric proteinsUNIV LELAND STANFORD JUNIOR·Filed 2018·Granted May 7, 2019·6 cites·18 claims
- 0395US9913826B2Compounds and compositions that bind and stabilize transthyretin and their use for inhibiting transthyretin amyloidosis and protein-protein interactionsUNIV LELAND STANFORD JUNIOR·Filed 2017·Granted Mar 13, 2018·15 cites·20 claims
- 0495US9308209B2Identification of stabilizers of multimeric proteinsUNIV LELAND STANFORD JUNIOR·Filed 2014·Granted Apr 12, 2016·12 cites·8 claims
- 0595US8877795B2Identification of stabilizers of multimeric proteinsGRAEF ISABELLA A·Filed 2011·Granted Nov 4, 2014·30 cites·8 claims
- 0693US11078162B2Processes for preparing AG-10, its intermediates, and salts thereofEIDOS THERAPEUTICS INC·Filed 2019·Granted Aug 3, 2021·5 cites·54 claims
- 0793US9169214B2Compounds and compositions that bind and stabilize transthyretin and their use for inhibiting transthyretin amyloidosis and protein-protein interactionsUNIV LELAND STANFORD JUNIOR·Filed 2013·Granted Oct 27, 2015·16 cites·28 claims
- 0892US9642838B2Compounds and compositions that bind and stabilize transthyretin and their use for inhibiting transthyretin amyloidosis and protein-protein interactionsUNIV LELAND STANFORD JUNIOR·Filed 2015·Granted May 9, 2017·8 cites·4 claims
- 0991US10842777B2Compounds and compositions that bind and stabilize transthyretin and their use for inhibiting transthyretin amyloidosis and protein-protein interactionsUNIV LELAND STANFORD JUNIOR·Filed 2019·Granted Nov 24, 2020·5 cites·9 claims
- 1090US11919865B2Processes for preparing AG-10, its intermediates, and salts thereofEIDOS THERAPEUTICS INC·Filed 2021·Granted Mar 5, 2024·1 cites·16 claims
- 1190US11337935B2Identification of stabilizers of multimeric proteinsUNIV LELAND STANFORD JUNIOR·Filed 2019·Granted May 24, 2022·2 cites·4 claims
- 1290US10398681B2Compounds and compositions that bind and stabilize transthyretin and their use for inhibiting transthyretin amyloidosis and protein-protein interactionsUNIV LELAND STANFORD JUNIOR·Filed 2018·Granted Sep 3, 2019·5 cites·4 claims
- 1390US2025313534A1Processes for preparing ag-10, its intermediates, and salts thereofEIDOS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1489US10513497B2Process for preparing AG-10, its intermediates, and salts thereofEIDOS THERAPEUTICS INC·Filed 2018·Granted Dec 24, 2019·6 cites·10 claims
- 1588US2024239751A1Processes for preparing ag-10, its intermediates, and salts thereofEIDOS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1684US2023390246A1Compounds and Compositions That Bind and Stabilize Transthyretin and Their Use for Inhibiting Transthyretin Amyloidosis and Protein-Protein InteractionsUNIV LELAND STANFORD JUNIOR·Filed 2023·Application pending·0 cites
- 1783US10172959B2Systems for stabilizing and delivering active agentsALHAMADSHEH MAMOUN M·Filed 2017·Granted Jan 8, 2019·4 cites·18 claims
- 1882US10363318B2Enhanced active agentsALHAMADSHEH MAMOUN M·Filed 2018·Granted Jul 30, 2019·3 cites·21 claims
- 1981US2023105307A1Identification of Stabilizers of Multimeric ProteinsUNIV LELAND STANFORD JUNIOR·Filed 2022·Application pending·0 cites
- 2079US2025186399A1Compounds and Compositions That Bind and Stabilize Transthyretin and Their Use for Inhibiting Transthyretin Amyloidosis and Protein-Protein InteractionsUNIV LELAND STANFORD JUNIOR·Filed 2025·Application pending·0 cites
- 2177US2025186366A1Identification of Stabilizers of Multimeric ProteinsUNIV LELAND STANFORD JUNIOR·Filed 2025·Application pending·0 cites
- 2276US10596269B2Delivering enhanced active agentsALHAMADSHEH MAMOUN M·Filed 2019·Granted Mar 24, 2020·1 cites·20 claims
- 2374US2021260034A1Compounds and Compositions That Bind and Stabilize Transthyretin and Their Use for Inhibiting Transthyretin Amyloidosis and Protein-Protein InteractionsUNIV LELAND STANFORD JUNIOR·Filed 2020·Application pending·0 cites
- 2473US7893268B2Epithiolone analoguesUNIV TOLEDO·Filed 2006·Granted Feb 22, 2011·1 cites·2 claims
- 2570US11129902B2Enhanced SN-38 anticancer agentALHAMADSHEH MAMOUN M·Filed 2020·Granted Sep 28, 2021·0 cites·32 claims
- 2668US10772967B2Enhanced anticancer agentALHAMADSHEH MAMOUN M·Filed 2020·Granted Sep 15, 2020·0 cites·20 claims
- 2753US2016045609A1Conjugation of pharmaceutically active agents with transthyretin ligands through adjustable linkers to increase serum half-lifeALHAMADSHEH MAMOUN M·Filed 2015·Application pending·0 cites
- 2841US8435983B2Conformationally restrained epothilone analogues as anti-leukemic agentsTILLEKERATNE VIRANGA·Filed 2008·Granted May 7, 2013·0 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when Mamoun M. Alhamadsheh files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →